These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17127360)

  • 1. The interaction between the renin-angiotensin system and peroxisome proliferator activated receptors: a hypothesis including the participation of mitochondria in aging.
    de Cavanagh EM; Piotrkowski B; Fraga CG
    Front Biosci; 2007 Jan; 12():1049-62. PubMed ID: 17127360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
    de Cavanagh EM; Inserra F; Ferder L
    Cardiovasc Res; 2011 Jan; 89(1):31-40. PubMed ID: 20819950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
    de Cavanagh EM; Inserra F; Ferder L
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging.
    de Cavanagh EM; Piotrkowski B; Fraga CG
    Mol Aspects Med; 2004; 25(1-2):27-36. PubMed ID: 15051314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From mitochondria to disease: role of the renin-angiotensin system.
    de Cavanagh EM; Inserra F; Ferder M; Ferder L
    Am J Nephrol; 2007; 27(6):545-53. PubMed ID: 17785964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
    Atarod EB; Kehrer JP
    Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.
    Valenzuela R; Costa-Besada MA; Iglesias-Gonzalez J; Perez-Costas E; Villar-Cheda B; Garrido-Gil P; Melendez-Ferro M; Soto-Otero R; Lanciego JL; Henrion D; Franco R; Labandeira-Garcia JL
    Cell Death Dis; 2016 Oct; 7(10):e2427. PubMed ID: 27763643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm.
    Duszka K; Wahli W
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33198317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
    Jing L; Li WM; Zhou LJ; Li S; Kou JJ; Song J
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1999-2007. PubMed ID: 18783396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.
    Duszka K; Gregor A; Guillou H; König J; Wahli W
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
    Agarwal S; Yadav A; Chaturvedi RK
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage.
    Colom B; Oliver J; Roca P; Garcia-Palmer FJ
    Cardiovasc Res; 2007 Jun; 74(3):456-65. PubMed ID: 17376413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system.
    Kim EN; Kim MY; Lim JH; Kim Y; Shin SJ; Park CW; Kim YS; Chang YS; Yoon HE; Choi BS
    Atherosclerosis; 2018 Mar; 270():123-131. PubMed ID: 29407880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain.
    Aleshin S; Reiser G
    Biol Chem; 2013 Dec; 394(12):1553-70. PubMed ID: 24021597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of PPAR in aging, inflammation, and calorie restriction.
    Sung B; Park S; Yu BP; Chung HY
    J Gerontol A Biol Sci Med Sci; 2004 Oct; 59(10):997-1006. PubMed ID: 15528772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
    Komar CM
    Reprod Biol Endocrinol; 2005 Aug; 3():41. PubMed ID: 16131403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and cardiovascular aging.
    Dai DF; Rabinovitch PS; Ungvari Z
    Circ Res; 2012 Apr; 110(8):1109-24. PubMed ID: 22499901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney.
    Speeckaert MM; Vanfraechem C; Speeckaert R; Delanghe JR
    Ageing Res Rev; 2014 Mar; 14():1-18. PubMed ID: 24503003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis.
    Verma S; Szmitko PE
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):12B-17B. PubMed ID: 16498507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.